You just read:

Novartis Recalls 100 mg Sandimmune and Neoral Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning

News provided by

U.S. Consumer Product Safety Commission

Mar 18, 2020, 17:43 ET